Histopathology Final Diagnosis Panel
- 16 Dec, 2019
- Written by Team Dr Lal PathLabs
Medically Approved by Dr. Shuchi
Table of Contents
Unleash the Potential of Digital Histopathology for Personalized Medicine
Test Highlights
A stepwise approach utilizing the unlimited number of lineage differentiation, lineage-specific, and cell-specific markers to establish a final diagnosis.
IHC panel selection is done by highly qualified experts at LPL.
Applications & Clinical Utility
Useful in diagnosis of carcinomas of unknown primary, hematolymphoid neoplasms, round cell tumors, and spindle cell neoplasms.
Each case reviewed and signed by two subject matter experts.
The test menu is exhaustive and is updated from time to time.
Digitized images of the slides can be stored and shared for any further opinion.
